Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: A large real-life worldwide populationMargherita Rimini, Min-Su Kang, Francesca Salani et al.|European Journal of Cancer|2024Cited by 47
Total Neoadjuvant Therapy for Locally Advanced Rectal CancerAlessandro Audisio, Francesco Fiorica, Chiara Gallio et al.|JAMA Oncology|2025Cited by 24
Prediction Model for Early-Stage Pancreatic Cancer Using Routinely Measured Blood BiomarkersLenka N.C. Boyd, Geert Kazemier, Mahsoem Ali et al.|JAMA Network Open|2023Cited by 17
Durvalumab in Advanced Biliary Tract Cancer: Real‐World Data From a Large Cohort of Patients Across Multiple International CentersMargherita Rimini, Su Yung‐Yeh, Lorenzo Fornaro et al.|Liver International|2025Cited by 10
Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide populationFederica Lo Prinzi, Monica Niger, Francesca Salani et al.|The Oncologist|2024Cited by 10